These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1115032)

  • 1. Mast cells and myelofibrosis.
    Udoji WC; Razavi SA
    Am J Clin Pathol; 1975 Feb; 63(2):203-9. PubMed ID: 1115032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stromal composition of mast cell aggregates in systemic mastocytosis.
    Chiu A; Nanaji NM; Czader M; Gheorghe G; Knowles DM; Chadburn A; Orazi A
    Mod Pathol; 2009 Jul; 22(7):857-65. PubMed ID: 19396155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agnogenic myeloid metaplasia.
    Block M
    Rev Bras Pesqui Med Biol; 1974; 7(2):185-95. PubMed ID: 4527643
    [No Abstract]   [Full Text] [Related]  

  • 5. Mast cell leukaemia: evidence for bone marrow origin of the pathological clone.
    Dalton R; Chan L; Batten E; Eridani S
    Br J Haematol; 1986 Oct; 64(2):397-406. PubMed ID: 3096368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bone marrow and splenic erythropoiesis in myelofibrosis.
    Ferrant A; Rodhain J; Cauwe F; Cogneau M; Beckers C; Michaux JL; Verwilghen R; Sokal G
    Scand J Haematol; 1982 Nov; 29(5):373-80. PubMed ID: 7156888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonic characterization of splenic tissue in myelofibrosis: further evidence for reversal of fibrosis with chemotherapy.
    Manoharan A; Chen CF; Wilson LS; Griffiths KA; Robinson DE
    Eur J Haematol; 1988 Feb; 40(2):149-54. PubMed ID: 3278929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic mastocytosis. Extracutaneous manifestations.
    Brunning RD; McKenna RW; Rosai J; Parkin JL; Risdall R
    Am J Surg Pathol; 1983 Jul; 7(5):425-38. PubMed ID: 6614308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilia in systemic mastocytosis.
    Yam LT; Yam CF; Li CY
    Am J Clin Pathol; 1980 Jan; 73(1):48-54. PubMed ID: 7352423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastocytosis with malabsorption, myelofibrosis, and massive ascites.
    Reisberg IR; Oyakawa S
    Am J Gastroenterol; 1987 Jan; 82(1):54-60. PubMed ID: 3799581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
    Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
    Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelofibrosis--pathophysiology and treatment.
    Cole DR; Pung J; Pung F; Cole DF
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):68-70. PubMed ID: 370037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological features of primary myelofibrosis from onset to blast transformation: report of two cases.
    Yonemitsu H; Kanazawa S; Kondo H; Okuda K
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):64-71. PubMed ID: 4003013
    [No Abstract]   [Full Text] [Related]  

  • 15. [The differential diagnosis of splenic angiosarcoma and idiopathic myelofibrosis].
    Suvorova EV; Al'pidovskiĭ VK; Semenova EA; Ershov IuA; Halig AA
    Gematol Transfuziol; 1989 Nov; 34(11):23-9. PubMed ID: 2612860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of idiopathic myelofibrosis with a prolonged and unusual course].
    Klimova NF; Popov VM
    Probl Gematol Pereliv Krovi; 1972 Aug; 17(8):50-3. PubMed ID: 4653728
    [No Abstract]   [Full Text] [Related]  

  • 17. Different composition of the erythropoietic tissue in bone marrow, spleen and liver in myelofibrosis.
    Sjögren U
    Acta Haematol; 1978; 59(4):231-6. PubMed ID: 417545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D-deficiency rickets and myelofibrosis.
    Yetgin S; Ozsoylu S; Ruacan S; Tekinalp G; Sarialioğlu F
    J Pediatr; 1989 Feb; 114(2):213-7. PubMed ID: 2536807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
    Thiele J; Kvasnicka HM; Czieslick C
    Ann Hematol; 2002 Feb; 81(2):86-9. PubMed ID: 11907788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation.
    Bentley SA; Murray KH; Lewis SM; Roberts PD
    Br J Haematol; 1977 May; 36(1):41-7. PubMed ID: 871424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.